Page 12 - மிதமான News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from மிதமான. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In மிதமான Today - Breaking & Trending Today
According to an advisory issued by the centre on Thursday, the situation has emerged due to overall below than average rainfall in the country from October 2020 to January 2021. ....
No casualties were reported, the Jakarta disaster mitigation agency s acting head Sabdo Kurnianto said in a statement on Saturday, the Xinhua news agency reported.Acco ....
Reps. Barry Loudermilk, R-Ga., and Greg Steube, R-Fla., condemned President Joe Biden s immigration policies and proposals Thursday on Newsmax TV, but also noted only a few moderate Democrats need to swim upstream to scuttle the Democrat plans. ....
News in brief: Car flips on roof, fire at refinery 18 Feb, 2021 04:00 PM 2 minutes to read People rush to help the elderly occupants of a car that flipped on its roof on Kiripaka Rd this morning. Photo / supplied People rush to help the elderly occupants of a car that flipped on its roof on Kiripaka Rd this morning. Photo / supplied Northern Advocate A car flipped on its roof on Kiripaka Rd in Tikipunga yesterday. A motorist, who did not want to be named, said he heard a bang shortly before 10am and saw an upside down vehicle. A large number of people stopped to help an elderly man and woman in the vehicle. A St John spokeswoman said paramedics treated one patient in a moderate condition. ....
DGAP-News: Immunic, Inc. Announces That Oral Treatment IMU-838 Shows Evidence of Clinical Activity in Moderate COVID-19 in Phase 2 CALVID-1 Trial Table: IMU-838 Shows Acceleration of Time to Clinical Improvement High-risk patients and patients aged over 65 years experienced a more substantial treatment benefit from IMU-838 than in the general patient population: - The 75% probability [5] to reach clinical improvement (based on investigator assessment) was accelerated by 3.8 days in IMU-838 treated high-risk patients [6], as compared to placebo (FAS). - The 75% probability [5] to reach clinical improvement (based on investigator assessment) was accelerated by 4.8 days in IMU-838 treated elderly patients (65 years or older), as compared to placebo (FAS). ....